Revenue | ₹731.67Cr |
Net Profits | ₹83.63Cr |
Net Profit Margins | 11.43% |
ERIS Lifesciences Ltd’s revenue jumped 49.17% since last year same period to ₹731.67Cr in the Q3 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -1.88% fall in its revenue since last 3-months.
ERIS Lifesciences Ltd’s net profit fell -18.6% since last year same period to ₹83.63Cr in the Q3 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -8.69% fall in its net profits since last 3-months.
ERIS Lifesciences Ltd’s net profit margin fell -45.43% since last year same period to 11.43% in the Q3 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -6.94% fall in its net profit margins since last 3-months.
The revenue for ERIS Lifesciences Ltd in the Q3 results 2024 was ₹731.67Cr.
The net profit for ERIS Lifesciences Ltd in the Q3 results 2024 was ₹83.63Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q3 results 2024 was 11.43%.
The revenue for ERIS Lifesciences Ltd in the Q3 results 2023 was ₹490.50Cr.
The net profit for ERIS Lifesciences Ltd in the Q3 results 2023 was ₹102.74Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q3 results 2023 was 20.95%.